August 20, 2010 07:52 AM Eastern Daylight Time

DUBLIN--(BUSINESS WIRE)--Research and Markets (Market of Paclitaxel Injection in China - Market Research Reports - Research and Markets) has announced the addition of the "Market of Paclitaxel Injection in China" report to their offering.

Nowadays, paclitaxel injection has been widely used to cure cancers like non-small cell lung cancer, breast cancer, and ovarian cancer, etc. Besides, paclitaxel injection has...

admin

Public release date: 19-Aug-2010

University of Alberta researcher Margie McNeely says results from an international study she was part of indicates certain precautions about the risk of lymphedema for breast cancer survivors are outdated.

McNeely, from the Faculty of Rehabilitation Medicine, says women who've had breast cancer surgery are often warned that pressure changes in an airplane cabin could trigger lymphedema, chronic swelling in the arm. But the study she did...

admin

19 Aug, 2010 14:55 CET

PITTSBURGH, Aug. 19 – Researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine have been awarded an $800,000 federal grant to develop agents to inhibit a cellular signaling protein that plays a key role in triggering and supporting the growth of many cancers, including cancers of the head and neck.

A member of a protein class called Signal Transducers and Activators of Transcription,...

admin

The PA Breast Cancer Coalition Announces Request for Applications for Income Tax Research Grants

EPHRATA, Pa., Aug. 19 /PRNewswire-USNewswire/ -- Are you a breast or cervical cancer researcher in PA looking for additional research funding? The PA Breast Cancer Coalition (PBCC) is awaiting your grant application for the PBCC's Income Tax Refunds for Breast and Cervical Cancer Research Grants. The grant funding cycle is July 1, 2011– June 30, 2012.

To download the Request...

admin

Abstract:
One of the first chemotherapy drugs given to patients diagnosed with cancer — especially lung, ovarian, or breast cancer — is cisplatin, a platinum-containing compound that binds to tumor cells' DNA. Cisplatin does a good job of killing those tumor cells, but it can also seriously damage the kidneys, which receive high doses of cisplatin because they filter the blood.

Improving Cisplatin with Nanoparticles

Bethesda, MD | Posted on August 18th, 2010
...

admin